Trials / Recruiting
RecruitingNCT04711746
Is Clonal Hematopoiesis of Indeterminate Potential Associated With Unprovoked Pulmonary Embolism?
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 544 (estimated)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The clonal hematopoiesis of indetermined prognosis (CHIP) has been described as risk factor for juvenile atherosclerosis. Moreover, some of CHIP genes are responsible of myeloproliferative disorders. Venous thrombosis are frequent in these disorders. The purpose of this project is to determine if CHIP is frequent in unprovoked pulmonary embolism and could be part of the pathophysiology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | blood sample | Blood sample withdrawal in order to perform DNA sequencing |
Timeline
- Start date
- 2021-02-01
- Primary completion
- 2026-01-01
- Completion
- 2026-01-01
- First posted
- 2021-01-15
- Last updated
- 2025-05-29
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04711746. Inclusion in this directory is not an endorsement.